Category: Uncategorized

September 11, 2019 Dedicated to Rare Disease TRiNDS is a neuromuscular and rare disease contract research organization (CRO). That means that our staffing, processes, and systems are designed with the unique needs of people with neuromuscular disorders and other rare diseases in mind. We know rare and orphan disease clinical trials face different struggles than… Read more »

Continuing Education Opportunity

August 28, 2019 Continuing Education Opportunity Before you can launch your new product for a rare disease, you need results from a clinical trial. Before you have your results, you need to fully enroll rare disease patients into the trial. Patients have more choices than ever before for participation in neuromuscular clinical trials. A common… Read more »

TRiNDS Patient Science Liaison Services

August 14, 2019 TRiNDS Patient Science Liaison Services Rare disease clinical drug development is stronger than ever – new mechanisms of action are being explored, breakthrough technology is getting ready to reach the clinic, and families are feeling more hopeful than ever for new therapies that could improve the quality of their lives. Clinical trials… Read more »

Cultivating Excellence at Work: TRiNDS Continuing Education

July 26, 2019 Cultivating Excellence at Work: TRiNDS Continuing Education TRiNDS is a unique partner in rare disease research in part due to our culture of excellence. We assemble expert teams who bring their specialized knowledge and experience to every project, every day. We foster collaboration, providing the highest level of service using the most… Read more »

TRiNDS Data Management Services

July 10, 2019 TRiNDS Data Management Services Every research project and every clinical trial need high quality, consistent, and accurate data to succeed. Without reliable data, it’s impossible to answer the critical scientific questions or to demonstrate an investigational product’s efficacy and safety. In rare disease trials, understanding which data points are correct and which… Read more »

Happy Summer from TRiNDS!

July 3, 2019 Happy Summer from TRiNDS! All of us at TRiNDS would like to wish you and your family a safe and fun summer season. Stay tuned to hear updates over the next few months about the work we’re doing to support innovation for neuromuscular and rare diseases. Contact us to learn more about… Read more »

FDA Draft Guidance: Increasing Diversity in Clinical Trials

June 26, 2019 FDA Draft Guidance: Increasing Diversity in Clinical Trials The Food and Drug Administration (FDA) recently released a new draft guidance entitled, “Enhancing the Diversity of Clinical Trial Populations – Eligibility Criteria, Enrollment Practices, and Trial Designs: Guidance for Industry.” As with other clinical trials, inclusion and exclusion criteria in rare disease trials… Read more »

FDA Draft Guidance: ANCOVA in Randomized Clinical Trials

May 23, 2019 FDA Draft Guidance: ANCOVA in Randomized Clinical Trials The Food and Drug Administration (FDA) has recently released a new draft guidance entitled, “Adjusting for Covariates in Randomized Clinical Trials for Drugs and Biologics with Continuous Outcomes – Guidance for Industry.” This document would build on the ICH guidance for industry, “E9 Statistical… Read more »

TRiNDS Annual Meeting

May 8, 2019 TRiNDS Annual Meeting TRiNDS is dedicated to clinical trials and research for people with neuromuscular and other rare diseases. Rare disease research is evolving quickly – the science is complex, the populations are small, and everyone wants to finish trials quickly. It takes a team of experts to reach rare disease research… Read more »

TRiNDS is Hiring

March 20, 2019 TRiNDS is hiring! TRiNDS has two job postings open in two cities at TRiNDS Careers. In Washington, DC we are looking for a contract Clinical Data Manager to join our data management team. The second opening is for an in-house Clinical Research Associate to work in our Pittsburgh, PA office with our… Read more »